Notably, we used datasets GSE105261 (9 primary KIRC vs. 26 matestasis of KIRC) and GSE22541 (24 primary KIRC vs. 24 matestasis of KIRC) from GEO database to study whether FRAS1/FREM could be tumor metastasis markers. Here, FRAS1 is linked to neoplasm.